Switch to:
GuruFocus has detected 1 Warning Sign with Cascadian Therapeutics Inc $CASC.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
Cascadian Therapeutics Inc (NAS:CASC)
Market Cap (M)
$210.72 Mil (As of Today)

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding (end-of-period, EOP). Cascadian Therapeutics Inc's share price for the quarter that ended in Mar. 2017 was $4.14. Cascadian Therapeutics Inc's shares outstanding (EOP) for the quarter that ended in Mar. 2017 was 49.22 Mil. Therefore, Cascadian Therapeutics Inc's market cap for the quarter that ended in Mar. 2017 was $203.77 Mil.

Cascadian Therapeutics Inc's quarterly market cap declined from Sep. 2016 ($221.89 Mil) to Dec. 2016 ($97.23 Mil) but then increased from Dec. 2016 ($97.23 Mil) to Mar. 2017 ($203.77 Mil).

Cascadian Therapeutics Inc's annual market cap increased from Dec. 2014 ($174.08 Mil) to Dec. 2015 ($210.86 Mil) but then declined from Dec. 2015 ($210.86 Mil) to Dec. 2016 ($97.23 Mil).

Enterprise value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Cascadian Therapeutics Inc's enterprise value for Today is $84.84 Mil.


Definition

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Cascadian Therapeutics Inc's Market Cap for the fiscal year that ended in Dec. 2016 is calculated as

Market Cap (A: Dec. 2016 )=Share Price (A: Dec. 2016 )*Shares Outstanding (EOP) (A: Dec. 2016 )
=4.31*22.56
=97.23

Cascadian Therapeutics Inc's Market Cap for the quarter that ended in Mar. 2017 is calculated as

Market Cap (Q: Mar. 2017 )=Share Price (Q: Mar. 2017 )*Shares Outstanding (EOP) (Q: Mar. 2017 )
=4.14*49.22
=203.77

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Related Terms

Shares Outstanding (EOP)


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Cascadian Therapeutics Inc Annual Data

Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15Dec16
mktcap 43.4915.54138.7498.00330.64109.90124.40174.08210.8697.23

Cascadian Therapeutics Inc Quarterly Data

Dec14Mar15Jun15Sep15Dec15Mar16Jun16Sep16Dec16Mar17
mktcap 174.08166.75355.00260.08210.86120.62127.63221.8997.23203.77
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

FEEDBACK